Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

West Pharmaceutical Services, Inc. WST

Healthcare  —  Medical Instruments & Supplies
370.44 (3.16) (0.85%) as of 25 Sep
Market cap
$26.3B
P/E
47.1×
S&P 500 Member Dividend Aristocrat
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

West Pharmaceutical Services, Inc. (WST) Price to free cash flow

As of 25 September 2026, West Pharmaceutical Services, Inc. (WST) trades at a price to free cash flow of 60.6×. Over the past ten years it has ranged from 35.9× (February 2026) to 137× (January 2017); the current reading is higher than 47% of that period. That is above the Medical Instruments & Supplies industry median of 25.7× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 42.8× (51.24%)
FY2024 87.7× 39.05%
FY2023 63.1× 57.56%
FY2022 40.0× (62.50%)
FY2021 107× 50.09%
FY2020 71.1× 53.42%
FY2019 46.4× 16.24%
FY2018 39.9× (29.36%)
FY2017 56.5× (57.02%)
FY2016 131× 137.89%

Quarterly

Period Price to free cash flow Change
Jun 2026 58.7× 47.71%
Mar 2026 39.7× (7.11%)
Dec 2025 42.8× (15.25%)
Sep 2025 50.5× 8.68%
42 more quarters

Against its own ten years

Low 35.9× High 137×
Ten-year median 61.5×
Current reading's percentile 47

Price to free cash flow against peers

Company Price to free cash flow
SOLV Solventum Corporation compare n/m
MDLN Medline Inc. compare 12.9×
BAX Baxter International Inc. compare 14.8×
COO The Cooper Companies, Inc. compare 15.8×
BDX Becton, Dickinson and Company compare 15.8×
ALC Alcon compare 19.7×
RMD ResMed Inc. compare 19.9×
WST West Pharmaceutical Services, Inc. 60.6×
RGEN Repligen Corporation compare 175×
Medical Instruments & Supplies industry median 25.7×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on WST